Results of surgical treatment of congenital cholesteatoma in children under 6 years old at the National Ear, Nose and Throat Hospital
Main Article Content
Abstract
This study aims to describe the surgical outcomes of congenital cholesteatoma in children. The study design is a retrospective longitudinal study with 208 patients at the National Ear, Nose and Throat Hospital from 2019 to 2024. Results: The majority of patients were in the early stages Potsic I–II (83.65%) and were indicated for exploratory tympanotomy (81.3%). During surgery, cholesteatoma was usually localized in the tympanic cavity (96.2%) and the tympanic quadrant (78.36%). No complication was reported right after surgery. Three months post-surgery, 100% of the ears had well-healed tympanic membranes, with no residual lesion. Hearing tests in 58 ears showed that 68.9% had Pure Tone Audiometry (PTA) ≤ 20 dB post-surgery, decreased slightly compared to pre-surgery but was not statistically significant (p = 0.067). Follow-up of ≥ 12 months revealed 4/37 (10.8%) residual cases in the Potsic IV group. Congenital cholesteatoma-conserving surgery in children yields good anatomical and functional results, with a low residual rate, and is particularly effective in the early stages.
Article Details
Keywords
Cholesteatoma, children, National Ear Nose Throat Hospital
References
2. Stapleton AL. Congenital CholesteatomaPredictors for Residual Disease and Hearing Outcomes. Arch Otolaryngol Neck Surg. 2012;138(3):280. doi:10.1001/archoto.2011.1422
3. Nevoux J, Lenoir M, Roger G, et al. Childhood cholesteatoma. Eur Ann Otorhinolaryngol Head Neck Dis. 2010;127(4):143-150. doi:10.1016/j.anorl.2010.07.001
4. Vangrinsven G, Bernaerts A, Deckers F, et al. Beyond the otoscope: an imaging review of congenital cholesteatoma. Insights Imaging. 2024;15(1):194. doi:10.1186/s13244-024-01761-1
5. Alfonso KP. Congenital Cholesteatoma. Otolaryngol Clin North Am. 2025;58(1):65-74. doi:10.1016/j.otc.2024.07.023
6. Derlacki EL, Clemis JD. LX Congenital Cholesteatoma of the Middle Ear and Mastoid. Ann Otol Rhinol Laryngol. 1965;74(3):706-727. doi:10.1177/000348946507400313
7. Committee on Hearing and Equilibrium. Committee on Hearing and Equilibrium Guidelines for the Evaluation of Results of Treatment of Conductive Hearing Loss. Otolaryngol Neck Surg. 1995;113(3):186-187. doi:10.1016/S0194-5998(95)70103-6
8. Potsic WP, Samadi DS, Marsh RR, et al. A Staging System for Congenital Cholesteatoma. Arch Otolaryngol Neck Surg. 2002;128(9):1009. doi:10.1001/archotol.128.9.1009
9. Park JH, Ahn J, Moon IJ. Transcanal Endoscopic Ear Surgery for Congenital Cholesteatoma. Clin Exp Otorhinolaryngol. 2018;11(4):233-241. doi:10.21053/ceo.2018.00122
10. James AL, Papsin BC. Some considerations in congenital cholesteatoma: Curr Opin Otolaryngol Head Neck Surg. 2013;21(5):431-439. doi:10.1097/MOO.0b013e328364b457
11. Cho HS, Kim HG, Jung DJ, et al. Clinical Aspects and Surgical Outcomes of Congenital Cholesteatoma in 93 Children: Increasing Trends of Congenital Cholesteatoma from 1997 through 2012. J Audiol Otol. 2016;20(3):168-173. doi:10.7874/jao.2016.20.3.168
12. Choi JE, Kang WS, Lee JD, et al. Outcomes of Endoscopic Congenital Cholesteatoma Removal in South Korea. JAMA Otolaryngol Neck Surg. 2023;149(3):231. doi:10.1001/jamaoto.2022.4660
13. Volgger V, Lindeskog G, Krause E, et al. Identification of risk factors for residual cholesteatoma in children and adults: a retrospective study on 110 cases of revision surgery. Braz J Otorhinolaryngol. 2020;86(2):201-208. doi:10.1016/j.bjorl.2018 .11.004